16 research outputs found
Fillability of small Seifert fibered spaces
No full textOn small Seifert fibered spaces M(e0; r1, r2, r3) with e0 ≠ -1, -2 all tight contact structures are Stein fillable. This is not the case for e0 = -1 or -2. However, for negative twisting structures it is expected that they are all symplectically fillable. Here, we characterise fillable structures among zero-twisting contact structures on small Seifert fibered spaces of the form M(-1;r1,r2,r3). The result is obtained by analysing monodromy factorizations of associated planar open books. © The Author(s), 2022. Published by Cambridge University Press on behalf of Cambridge Philosophical Society
Analysis of Influence of Basketball Game-Related Statistics on Final Result Based on Differences at the 2017 FIBA Asia Cup
No full textBook Reviews
No full textBook Review 1Book Title: Paediatric osteology. Prevention of osteoporosis - a paediatric task?Book Authors: Eckhard Schönau & V Matkovic (Ed.)Pp. ix + 276. Elsevier Science B.V 1998. ISBN 0-444-82840-0.Book Review 2Book Title: Molecular and cell biology of type 2 diabetes and its complicationsBook Author: F Belflore, M Lorenzi, G.M. Molinatatti & M PortaPp. x + 260. Karger. 1998. ISBN 3-8055-6644-1
Comparative values, correlation and classification of basketball players based on the efficiency index and expert evaluation by coaches
No full textMeasuring the efficiency of athletes during competition has been a subject of interest both for experts and scientists in sports for more than a hundred years. Basketball has recognized in the 1940s how important it is to analyze efficiency indicators because these procedures allow coaches to increase their knowledge. There are two basic methods – objective and subjective – for evaluating the efficiency, or real quality of basketball players. The aim of this research is to establish the level of correlation between these two methods and to identify clusters, i.e. player hierarchy based on the results of both methods of efficiency evaluation. The sample of variables consisted of 12 basketball players who participated in the 2010 FIBA World Championships in Turkey. The subjective evaluation, also called expert evaluation, was performed by coaches of seven national teams that participated in the Championship. The objective evaluation was performed using the EEF efficiency index. The data was processed using z-scoring, the Pearson coefficient, and hierarchical cluster analysis. The Pearson coefficients of linear correlation between the efficiency index and the expert evaluation is r = 0.859 with a statistical significance of p ≤ 0.01. The cluster analysis distinguished two groups of players, which were named quality and super quality. The variance analysis showed that the probability of the clusters being equal is less than p ≤ 0.00. The research has shown that the evaluation by coaches is relevant and is fully consistent with the efficiency index formula. Also, the distinction of two groups of players by clustering is not uncommon in the basketball practice and is linked with efficiency at the given time
Female Authors under the Mask of a Male Pseudonym - Some Approaches to Revealing Authors’ Gender
No full textA patriarchal society has very clear and rigid norms. Its frame does not allow one to move out of it, and a mode of behaviour which attempts any change is severely punished. This kind of society has strict written and unwritten rules, and it seems that the second kind are more harmful and painful for the individual than the first. In 19th century, European society was strongly patriarchal, and a phenomenon which confirms this is the fact that many female writers published their works under a male pseudonym. A patriarchal system attempts to prevent women from any artistic and scientific form and expression, as they are labelled as less intellectually able or talented, but by choosing a male pseudonym they found a way to reach their goal. An author writes about what he knows, what surrounds him and/or what he notices, feels and thinks. Considering that a patriarchal society system is highly defined, female and male points of view, their angles of reflection and aims are obviously different. In novels, choice of character and situation and the description of such, can easily reveal an author’s gender. These approaches will be illustrated by analysing the work of Vincenza Speraz, who lived in North Italy between the 19th and 20th centuries, and published her works under the pseudonym Bruno Sperani.</jats:p
Galaxy And Mass Assembly (GAMA) : stellar mass functions by Hubble type
No full textThis work was supported by the Austrian Science Foundation FWF under grant P23946. AWG was supported under the Australian Research Council's funding scheme FT110100263.We present an estimate of the galaxy stellar mass function and its division by morphological type in the local (0.025 < z < 0.06) Universe. Adopting robust morphological classifications as previously presented (Kelvin et al.) for a sample of 3727 galaxies taken from the Galaxy And Mass Assembly survey, we define a local volume and stellar mass limited sub-sample of 2711 galaxies to a lower stellar mass limit of M = 109.0 MΘ. We confirm that the galaxy stellar mass function is well described by a double-Schechter function given by Μ* = 1010.64 MΘ, α1 = 0.43, φ1* = 4.18 dex-1 Mpc-3, α2 = −1.50 and φ2* = 0.74 dex-1 Mpc-3. The constituent morphological-type stellar mass functions are well sampled above our lower stellar mass limit, excepting the faint little blue spheroid population of galaxies. We find approximately 71-4+3 per cent of the stellar mass in the local Universe is found within spheroid-dominated galaxies; ellipticals and S0-Sas. The remaining 29-3+4 per cent falls predominantly within late-type disc-dominated systems, Sab-Scds and Sd-Irrs. Adopting reasonable bulge-to-total ratios implies that approximately half the stellar mass today resides in spheroidal structures, and half in disc structures. Within this local sample, we find approximate stellar mass proportions for E : S0-Sa : Sab-Scd : Sd-Irr of 34 : 37 : 24 :5.Peer reviewe
Negative effect of leptin on bone mass in type 1 diabetes
No full textStudies investigating the effect of leptin on bone mass were inconsistent and some related it to the effect of insulin. We intend in this cross-sectional study to investigate the effect of leptin on bone mass in type 1 diabetic patients. We recruited 42 patients with type 1 diabetes for which we determined weight, height, HbA1c, microalbuminuria, serum leptin, bone mineral content (BMC) and density (BMD), and body composition. The patients had an average age of 20.1 ± 0.6 years, an average body mass index (BMI) of 23.6 ± 0.5 kg-cm2 and an average duration of diabetes of 9.1 ± 1.0 years. The Z-score was not correlated with HbA1c or duration of the disease, and the average Z-score was not different in patients with microalbuminuria as compared to patients with no reported microalbuminuria. On the other hand, Z-score and BMC correlated negatively with leptin (r = -0.31; p = 0.04 and -0.60, p andlt; 0.01, respectively). These correlations persisted after adjustment for fat mass. We conclude that not metabolic control of diabetes, but serum leptin has a negative effect on bone density in young patients with type 1 diabetes. This negative effect of leptin on bone density maybe, in part, due to deficiency of endogenous insulin secretion in these patients. © 2008 Springer-Verlag.Abou Samra R, 2005, J CLIN ENDOCR METAB, V90, P2588, DOI 10.1210-jc.2004-2049; Alexopoulou O, 2006, DIABETES METAB, V32, P453, DOI 10.1016-S1262-3636(07)70303-8; Bartos V, 2001, Cas Lek Cesk, V140, P299; Blum M, 2003, CALCIFIED TISSUE INT, V73, P27, DOI 10.1007-s00223-002-1019-4; Chau Diane L, 2003, Curr Diab Rep, V3, P37, DOI 10.1007-s11892-003-0051-8; Ducy P, 2000, CELL, V100, P197, DOI 10.1016-S0092-8674(00)81558-5; Goulding A, 1998, CALCIFIED TISSUE INT, V63, P456, DOI 10.1007-s002239900557; HUI SL, 1985, J CLIN ENDOCR METAB, V60, P74; Iwamoto I, 2000, ACTA OBSTET GYN SCAN, V79, P1060, DOI 10.1034-j.1600-0412.2000.0790121060.x; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941; KIEL D, 1999, J BONE MINER RES, V14, P475; Kontogianni MD, 2004, J BONE MINER RES, V19, P546, DOI 10.1359-JBMR.040107; LEVIN ME, 1976, NEW ENGL J MED, V294, P241, DOI 10.1056-NEJM197601292940502; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038-nm0995-950; López-Ibarra P J, 2001, Endocr Pract, V7, P346; Martini G, 2001, BONE, V28, P113, DOI 10.1016-S8756-3282(00)00408-7; Matkovic V, 1997, J CLIN ENDOCR METAB, V82, P3239, DOI 10.1210-jc.82.10.3239; MCNAIR P, 1981, EUR J CLIN INVEST, V11, P55, DOI 10.1111-j.1365-2362.1981.tb01765.x; Miazgowski T, 1998, OSTEOPOROSIS INT, V8, P399, DOI 10.1007-s001980050082; Morberg CM, 2003, J CLIN ENDOCR METAB, V88, P5795, DOI 10.1210-jc.2003-030496; Odabasi E, 2000, EUR J ENDOCRINOL, V142, P170, DOI 10.1530-eje.0.1420170; OLMOS JM, 1994, BONE MINER, V26, P1, DOI 10.1016-S0169-6009(08)80157-2; Ormarsdottir S, 2001, J GASTROEN HEPATOL, V16, P1409, DOI 10.1046-j.1440-1746.2001.02631.x; Pasco JA, 2001, J CLIN ENDOCR METAB, V86, P1884, DOI 10.1210-jc.86.5.1884; Rauch F, 1998, CALCIFIED TISSUE INT, V63, P453, DOI 10.1007-s002239900556; Rozadilla A, 2000, JOINT BONE SPINE, V67, P215; Ruhl CE, 2002, J BONE MINER RES, V17, P1896, DOI 10.1359-jbmr.2002.17.10.1896; Sato M, 2001, J CLIN ENDOCR METAB, V86, P5273, DOI 10.1210-jc.86.11.5273; SIMON EV, 2000, AN ESP PEDIATR, V52, P507; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359-jbmr.2002.17.9.1563; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210-en.140.4.1630; Watanabe S, 2003, J BONE MINER METAB, V21, P166, DOI 10.1007-s007740300026; Yamauchi M, 2001, CLIN ENDOCRINOL, V55, P341, DOI 10.1046-j.1365-2265.2001.01361.x43
Impact of seafood and fruit consumption on bone mineral density
No full textObjectives: Over the past decade, dietary choices and nutrition have proven to be major modulators of bone mineral density (BMD) in men and women. We investigated environmental determinants, specifically dietary habits, of BMD by using multiple regression models in a rural Chinese population. Methods: BMDs were measured at the hip and total body in 5848 men and 6207 women, aged 25-64. Dietary and supplemental intakes were assessed by a simple, one-page questionnaire tailored to collect nutritional information from large rural populations. Another questionnaire was used to collect information on the subjects' age, disease history, smoking, alcohol consumption, physical activity as well as women's menstrual status and reproductive history. Multiple regression models were used to assess the relationships among dietary variables and BMD, after adjusting for age, BMI (body mass index), weight, occupation, smoking status, and alcohol consumption. Results: Increasing seafood consumption was significantly associated with greater BMD in women (p 0.001), especially those consuming more than 250 g per week of seafood. One thousand and three hundred and twenty-four men and 1479 women consumed 250 g of fruit per week. Higher fruit intake was found to be significantly associated with higher BMD in both sexes (p 0.05). High vegetable consumption, however, did not positively impact BMD. Conclusions: This study with its large population size has identified preventive measures, as well as some risk factors, involved in bone loss and osteoporosis. Our results highlight the importance of several dietary variables as significant determinants of BMD. It also emphasizes the role of dietary intake in general and shows that specific foods, such as fruits and seafood, can positively impact BMD. © 2006 Elsevier Ireland Ltd. All rights reserved.Albertazzi P, 2002, MATURITAS, V42, P13, DOI 10.1016-S0378-5122(02)00022-1; ANGUS RM, 1988, BONE MINER, V4, P265; Bacon L, 2004, EUR J CLIN NUTR, V58, P966, DOI 10.1038-sj.ejcn.1601922; CHAN JCM, 1981, FED PROC, V40, P2423; COETZER H, 1994, PROSTAG LEUKOTR ESS, V50, P257, DOI 10.1016-0952-3278(94)90164-3; Eisman JA, 1999, ENDOCR REV, V20, P788, DOI 10.1210-er.20.6.788; Fernandes G, 2003, PROSTAG LEUKOTR ESS, V68, P361, DOI 10.1016-S0952-3278(03)00060-7; Grajeta Halina, 2003, Przegl Lek, V60, P649; Heaney R. P., 2000, J AM COLL NUTR S, V19, P83; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; KANIS JA, 1994, J BONE MINER RES, V9, P1137; Kitchin B, 2003, CURR OPIN RHEUMATOL, V15, P476, DOI 10.1097-00002281-200307000-00017; Kruger MC, 1997, PROG LIPID RES, V36, P131, DOI 10.1016-S0163-7827(97)00007-6; Li NH, 2002, CHINESE MED J-PEKING, V115, P773; Livshits G, 2004, J BONE MINER RES, V19, P914, DOI 10.1359-JBMR.040132; Macdonald HM, 2004, AM J CLIN NUTR, V79, P155; Masse PG, 2004, J HUM NUTR DIET, V17, P121, DOI 10.1111-j.1365-277X.2004.00508.x; MATKOVIC V, 1990, AM J CLIN NUTR, V52, P878; Mitchell BD, 2003, BONE, V33, P839, DOI 10.1016-S8756-3282(03)00246-1; New SA, 1997, AM J CLIN NUTR, V65, P1831; Prentice A, 2001, P NUTR SOC, V60, P45, DOI 10.1079-PNS200072; Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079-PHN2003590; SEBASTIAN A, 1994, NEW ENGL J MED, V330, P1776, DOI 10.1056-NEJM199406233302502; SEELIG MS, 1993, J AM COLL NUTR, V12, P442; SMITH DM, 1973, J CLIN INVEST, V52, P2800, DOI 10.1172-JCI107476; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359-jbmr.2003.18.7.1206; Terano T, 2001, WORLD REV NUTR DIET, V88, P141; Teucher B, 2003, P NUTR SOC, V62, P859, DOI 10.1079-PNS2003300; TRANQUILLI AL, 1994, GYNECOL ENDOCRINOL, V8, P55, DOI 10.3109-09513599409028459; Tucker Katherine L., 2003, Current Pharmaceutical Design, V9, P2687, DOI 10.2174-1381612033453613; Tucker KL, 1999, AM J CLIN NUTR, V69, P727; WACHMAN A, 1968, LANCET, V1, P958; Watkins BA, 2001, PROG LIPID RES, V40, P125, DOI 10.1016-S0163-7827(00)00016-3; Whiting SJ, 2004, J NUTR, V134, p696S39393
Understanding how junction resistances impact the conduction mechanism in nano-networks
No full textFunding Information: We acknowledge funding from the European Union through the ERC grant FUTUREPRINT, the Graphene Flagship and the Horizon Europe project 2D-PRINTABLE (GA-101135196). We have also received support from the Science Foundation Ireland (SFI) funded centre AMBER (SFI/12/ RC/2278_P2) and availed of the facilities of the SFI-funded advanced microscopy laboratory (AML), additive research laboratory (ARL) and iCRAG. A.G.K. acknowledges funding from the Marie Skłodowska-Curie Postdoctoral Fellowship “NanoHarvest” (Proposal Number: 101107032). T.C. acknowledges funding from a Marie Skłodowska-Curie Individual Fellowship “MOVE” (grant number 101030735, project number 211395, and award number 16883). L.D appreciates support from Science Foundation Ireland (SFI) (18/EPSRC-CDT/3581). E.Ca appreciates support from the Irish Research Council (IRC) (GOIPG/2020/1051). J.M. acknowledges his Margarita Salas fellowship from the Spanish Ministry of Universities. A.M. acknowledges support from the European Research Council Starting Grant POL_2D_PHYSICS (101075821) and the Austrian Science Fund Y1298-N START Prize. NY is funded by the SFI US-Ireland project (21/US/3788). G.G., S.K. and L.D.A.S. received funding from the Netherlands Organisation for Scientific Research (NWO) in the frame- work of the Materials for sustainability and from the Ministry of Economic Affairs in the framework of the PPP allowance. Z.S. was supported by ERC-CZ program (project LL2101) from Ministry of Education Youth and Sports (MEYS) and acknowledges laser infrastructure from project reg. No. CZ.02.1.01/0.0/0.0/15_003/0000444 financed by the EFRR. We thank Prof. Matthias Moebius for useful discussions. Publisher Copyright: © The Author(s) 2024.Networks of nanowires, nanotubes, and nanosheets are important for many applications in printed electronics. However, the network conductivity and mobility are usually limited by the resistance between the particles, often referred to as the junction resistance. Minimising the junction resistance has proven to be challenging, partly because it is difficult to measure. Here, we develop a simple model for electrical conduction in networks of 1D or 2D nanomaterials that allows us to extract junction and nanoparticle resistances from particle-size-dependent DC network resistivity data. We find junction resistances in porous networks to scale with nanoparticle resistivity and vary from 5 Ω for silver nanosheets to 24 GΩ for WS2 nanosheets. Moreover, our model allows junction and nanoparticle resistances to be obtained simultaneously from AC impedance spectra of semiconducting nanosheet networks. Through our model, we use the impedance data to directly link the high mobility of aligned networks of electrochemically exfoliated MoS2 nanosheets (≈ 7 cm2 V−1 s−1) to low junction resistances of ∼2.3 MΩ. Temperature-dependent impedance measurements also allow us to comprehensively investigate transport mechanisms within the network and quantitatively differentiate intra-nanosheet phonon-limited bandlike transport from inter-nanosheet hopping.publishersversionpublishe
Vitamin D: A growing perspective
No full textVitamin D deficiency has been widely reported in all age groups in recent years. Rickets has never been eradicated in developed countries, and it most commonly affects children from recent immigrant groups. There is much evidence that current vitamin D guidelines for the neonatal period, 5-10 μ g (200-400 IU)-day, prevent rickets at the typical calcium intakes in developed countries. The annual incidence of vitamin D-deficiency rickets in developed countries ranges between 2.9 and 7.5 cases per 100,000 children. The prevalence of vitamin D deficiency in mothers and their neonates is remarkable, and the results of one study suggest that third-trimester 25-hydroxyvitamin D (25(OH)D) is associated with fetal bone mineral accrual that may affect prepubertal bone mass accumulation. Beyond infancy, the evidence indicates that 5 μ g (200 IU)-day of vitamin D has little effect on vitamin D status as measured by the serum 25(OH)D concentration. Two randomized clinical trials show that higher vitamin D intake improves one-year gain in bone density in adolescent girls. The functions of vitamin D extend beyond bone to include immune system regulation and anti-proliferative effects on cells. Early life vitamin D inadequacy is implicated in the risk of bone disease, autoimmune disease, and certain cancers later in life; however, long-term interventional studies do not exist to validate the widespread implementation of greater vitamin D consumption. Here we review the available data concerning vitamin D status and health effects of vitamin D in pregnancy through to and including adolescence. Copyright © 2008 Informa Healthcare USA, Inc.Abrams SA, 2005, J CLIN ENDOCR METAB, V90, P5576, DOI 10.1210-jc.2005-1021; Abrams SA, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P811; Abrams SA, 2002, NUTR REV, V60, P111, DOI 10.1301-00296640260085840; Adorini L, 2003, ANN NY ACAD SCI, V987, P258; Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136-adc.87.2.111; AHMED I, 1995, ACTA PAEDIATR, V84, P941, DOI 10.1111-j.1651-2227.1995.tb13798.x; Ainy E, 2006, J ENDOCRINOL INVEST, V29, P303; AKSNES L, 1982, J CLIN ENDOCR METAB, V55, P94; ALAHOUHALA M, 1988, ACTA PAEDIATR SCAND, V77, P89, DOI 10.1111-j.1651-2227.1988.tb10604.x; ALAHOUHALA M, 1985, J PEDIATR GASTR NUTR, V4, P220, DOI 10.1097-00005176-198504000-00011; ALAHOUHALA M, 1988, AM J CLIN NUTR, V48, P1057; ALAHOUHALA M, 1986, ARCH DIS CHILD, V61, P1159; ALAHOUHALA M, 1984, ACTA PAEDIATR SCAND, V73, P232, DOI 10.1111-j.1651-2227.1984.tb09934.x; ALFAHIM M, 1995, BRIT J NUTR, V73, P881, DOI 10.1079-BJN19950093; ALROY I, 1995, MOL CELL BIOL, V15, P5789; Etzel RA, 1999, PEDIATRICS, V104, P328; Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038-sj.ejcn.1602108; Anderson PH, 2003, J MOL ENDOCRINOL, V31, P123, DOI 10.1677-jme.0.0310123; Arabi A, 2004, BONE, V35, P1169, DOI 10.1016-j.bone.2004.06.015; Araya Z, 2003, BIOCHEM J, V372, P529, DOI 10.1042-BJ20021651; Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210-jc.2004-0360; Armbrecht HJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P298, DOI 10.1016-S0003-9861(02)00636-7; Ashraf S, 2002, ARCH DIS CHILD, V87, P263, DOI 10.1136-adc.87.3.263-a; Aubin JE, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P649; Baas D, 2000, GLIA, V31, P59, DOI 10.1002-(SICI)1098-1136(200007)31:159::AID-GLIA603.0.CO;2-Y; BALLABRIGA A, 2000, EUR J CLIN NUTR S1, V54, P1; Barsony J, 2002, VITAM HORM, V65, P345, DOI 10.1016-S0083-6729(02)65071-X; BASHIR T, 1981, J HUM NUTR, V35, P49; Bassir M, 2001, ACTA PAEDIATR, V90, P577, DOI 10.1080-080352501750197755; BELTON NR, 1986, ACTA PAEDIATR SC S, V326, pS68; Better O S, 1980, Adv Exp Med Biol, V128, P467; Bettica P, 1999, OSTEOPOROSIS INT, V9, P226, DOI 10.1007-s001980050141; Bezerra F, 2004, AM J CLIN NUTR, V80, P1322; Bhattoa HP, 2004, OSTEOPOROSIS INT, V15, P447, DOI 10.1007-s00198-003-1566-1; Bianda T, 1998, J CLIN ENDOCR METAB, V83, P81, DOI 10.1210-jc.83.1.81; BIDMON HJ, 1991, EXPERIENTIA, V47, P958, DOI 10.1007-BF01929891; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023-A:1017535728844; Bischoff HA, 1999, ARCH PHYS MED REHAB, V80, P54, DOI 10.1016-S0003-9993(99)90307-6; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001-jama.293.18.2257; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001-jama.291.16.1999; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016-j.amjmed.2003.12.029; Biser-Rohrbaugh A, 2001, J PEDIATR ORTHOPED, V21, P508, DOI 10.1097-00004694-200107000-00017; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016-j.jsbmb.2004.03.115; BLUMSOHN A, 1994, CLIN ENDOCRINOL, V40, P663, DOI 10.1111-j.1365-2265.1994.tb03019.x; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210-jc.2007-0718; Bodnar LM, 2007, J NUTR, V137, P447; BOLAND R, 1986, ENDOCR REV, V7, P434; BONET AM, 2002, AN ESP PEDIATR, V57, P264; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555; Bonofiglio D, 2000, BRIT J NUTR, V84, P111; Bonofiglio D, 1999, HORM METAB RES, V31, P478, DOI 10.1055-s-2007-978779; Boot AM, 1997, AM J CLIN NUTR, V66, P232; BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172-JCI110072; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210-er.16.2.200; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; BROOKE OG, 1980, BRIT MED J, V280, P751; BROOKE OG, 1981, BRIT MED J, V283, P1024; BROOKE OG, 1981, BRIT J OBSTET GYNAEC, V88, P18, DOI 10.1111-j.1471-0528.1981.tb00931.x; Brouwer DAJ, 1998, BRIT J NUTR, V79, P527, DOI 10.1079-BJN19980091; BROWN I R F, 1980, Biochemical Society Transactions, V8, P136; Brukner P, 1998, SPORTS MED, V26, P415, DOI 10.2165-00007256-199826060-00004; CADRANEL J, 1990, J CLIN INVEST, V85, P1588, DOI 10.1172-JCI114609; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210-er.17.4.333; CANALIS E, 1991, ENDOCRINOLOGY, V129, P2457; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017-S0950268806007175; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073-pnas.93.15.7861; CARRASCOSA A, 1988, ESP PEDIAT S35, V29, pS1; Carvalho NF, 2001, PEDIATRICS, V107, DOI 10.1542-peds.107.4.e46; CHAN GM, 1995, J PEDIATR, V126, P551, DOI 10.1016-S0022-3476(95)70348-9; CHAN GM, 1987, AM J CLIN NUTR, V46, P319; CHAN GM, 1984, AM J DIS CHILD, V138, P569; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056-NEJM199212033272305; Chaudhari Sudha, 2004, Indian Pediatr, V41, P121; Cheng J C, 1993, J Orthop Trauma, V7, P15, DOI 10.1097-00005131-199302000-00004; Cheng JCY, 1999, J PEDIATR ORTHOPED, V19, P344, DOI 10.1097-00004694-199905000-00011; Cheng S, 2005, AM J CLIN NUTR, V82, P1115; Cheng SL, 2003, AM J CLIN NUTR, V78, P485; CHESNEY RW, 1980, AM J DIS CHILD, V134, P135; Chesney RW, 2002, CLIN PEDIATR, V41, P137, DOI 10.1177-000992280204100301; Clark EM, 2006, J BONE MINER RES, V21, P1489, DOI 10.1359-JBMR.060601; Clark EM, 2006, PEDIATRICS, V117, P291; CLEMENTS MR, 1992, CLIN ENDOCRINOL, V37, P17, DOI 10.1111-j.1365-2265.1992.tb02278.x; CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038-325062a0; COCKBURN F, 1980, BRIT MED J, V281, P11; CONGDON P, 1983, BRIT MED J, V286, P1233; COOKE NE, 1989, ENDOCR REV, V10, P294; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007-s00198-005-2039-5; COOPER C, 1995, J BONE MINER RES, V10, P940; Crabtree NJ, 2004, BONE, V35, P965, DOI 10.1016-j.bone.2004.06.009; CROSS NA, 1995, AM J CLIN NUTR, V61, P514; DAGNELIE PC, 1990, AM J CLIN NUTR, V51, P202; Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89; Das G, 2006, ARCH DIS CHILD, V91, P569, DOI 10.1136-adc.2005.077974; Datt S, 2002, BJOG-INT J OBSTET GY, V109, P905, DOI 10.1016-S1470-0328(02)01171-0; Davies JH, 2005, ARCH DIS CHILD, V90, P373, DOI 10.1136-adc.2004.053553; Davies PSW, 1999, EUR J CLIN NUTR, V53, P195, DOI 10.1038-sj.ejcn.1600697; Dawodu A, 2003, J PEDIATR-US, V142, P169, DOI 10.1067-mpd.2003.63; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007-s00198-005-1867-7; DAWSONHUGHES B, 1991, ANN INTERN MED, V115, P505; DAWSONHUGHES B, 1995, AM J CLIN NUTR, V61, P1140; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056-NEJM199709043371003; de Ridder Christine M., 1998, Current Opinion in Pediatrics, V10, P441, DOI 10.1097-00008480-199808000-00020; DELVIN EE, 1987, EUR J BIOCHEM, V163, P659, DOI 10.1111-j.1432-1033.1987.tb10915.x; DELVIN EE, 1985, J CLIN ENDOCR METAB, V60, P880; DELVIN EE, 1986, J PEDIATR, V109, P328, DOI 10.1016-S0022-3476(86)80396-1; DELVIN EE, 1982, ARCH DIS CHILD, V57, P754; de Lyra EC, 2006, J STEROID BIOCHEM, V100, P184, DOI 10.1016-j.jsbmb.2006.04.009; Dennison EM, 2005, PEDIATR RES, V57, P582, DOI 10.1203-01.PDR.0000155754.67821.CA; DENT CE, 1969, Q J MED, V38, P195; Di Cesar DJ, 2006, DIABETES CARE, V29, P174, DOI 10.2337-diacare.29.01.06.dc05-1876; DLUGOS DJ, 1995, UNDERSEA HYPERBAR M, V22, P145; Docio S, 1998, J BONE MINER RES, V13, P544, DOI 10.1359-jbmr.1998.13.4.544; Dong XY, 2003, J BIOL CHEM, V278, P49378, DOI 10.1074-jbc.M308448200; Du XQ, 2001, AM J CLIN NUTR, V74, P494; DUELAND S, 1983, AM J PHYSIOL, V245, pE463; Dumont M, 1991, J Gynecol Obstet Biol Reprod (Paris), V20, P995; DUNNIGAN M G, 1962, Scott Med J, V7, P159; ELLIS G, 1977, LANCET, V1, P825; Embry AF, 2000, ANN NEUROL, V48, P271, DOI 10.1002-1531-8249(200008)48:2271::AID-ANA283.0.CO;2-O; Eugster E A, 1996, Minn Med, V79, P29; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016-S0306-4522(03)00040-X; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016-j.jchemneu.2004.08.006; Faibish D, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P477; Fares JE, 2003, BONE, V33, P242, DOI 10.1016-S8756-3282(03)00160-1; Faulkner RA, 2006, J BONE MINER RES, V21, P1864, DOI 10.1359-JBMR.060907; FELDMAN KW, 1990, AM FAM PHYSICIAN, V42, P1311; FLEISCHMAN AR, 1980, J PEDIATR, V97, P640, DOI 10.1016-S0022-3476(80)80030-8; FOGELMAN Y, 1995, ISRAEL J MED SCI, V31, P221; FORBES GB, 1976, PEDIATRICS, V57, P976; FRASER DR, 1980, PHYSIOL REV, V60, P551; Fukazawa T, 1999, J NEUROL SCI, V166, P47, DOI 10.1016-S0022-510X(99)00112-4; FULEIHAN GE, 2007, INT C SERIES, V1297, P91; Fuleihan GEH, 2001, PEDIATRICS, V107, DOI 10.1542-peds.107.4.e53; Fuleihan GE, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210-jc.2005-1436; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016-S1043-2760(01)00547-1; Garcion E, 2003, ACTA NEUROPATHOL, V105, P438, DOI 10.1007-s00401-002-0663-0; Garnero P, 1996, J BONE MINER RES, V11, P1531; GASTEELS KM, 1998, ENDOCRINOLOGY, V139, P95; GELANDER L, 1994, ACTA PAEDIATR, V83, P1249, DOI 10.1111-j.1651-2227.1994.tb13006.x; GERTNER JM, 1980, J PEDIATR, V97, P637, DOI 10.1016-S0022-3476(80)80029-1; Gessner BD, 2003, J PEDIATR, V143, P434, DOI 10.1067-S00223476(03)00410-4; Ghazi AAM, 2004, J ENDOCRINOL INVEST, V27, P676; GILSANZ V, 1988, CALCIFIED TISSUE INT, V43, P260, DOI 10.1007-BF02555144; Ginty F, 2004, EUR J CLIN NUTR, V58, P1257, DOI 10.1038-sj.ejcn.1601959; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007-s10552-004-1661-4; GLASTRE C, 1990, J CLIN ENDOCR METAB, V70, P1330; GLOTH FM, 1995, JAMA-J AM MED ASSOC, V274, P1683, DOI 10.1001-jama.274.21.1683; Godel JC, 2007, PAEDIATR CHILD HEALT, V12, P583; GOLDBERG P, 1986, MED HYPOTHESES, V21, P193, DOI 10.1016-0306-9877(86)90010-1; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016-j.tibtech.2004.05.001; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001-archpedi.158.6.531; Goulding A, 1998, J BONE MINER RES, V13, P143, DOI 10.1359-jbmr.1998.13.1.143; Goulding A, 2001, J PEDIATR, V139, P509, DOI 10.1067-mpd.2001.116297; Grant WB, 2002, J INTERN MED, V252, P178, DOI 10.1046-j.1365-2796.2002.01016.x; Grant WB, 2005, PHOTOCHEM PHOTOBIOL, V81, P1276, DOI 10.1562-2005-01-24-RA-424; GREER FR, 1989, J PEDIATR, V114, P204, DOI 10.1016-S0022-3476(89)80784-X; GREER FR, 1984, J PEDIATR, V105, P431, DOI 10.1016-S0022-3476(84)80021-9; GREER FR, 1988, J PEDIATR, V112, P961, DOI 10.1016-S0022-3476(88)80227-0; GREER FR, 1984, AM J CLIN NUTR, V40, P562; GREER FR, 1982, J PEDIATR, V100, P919, DOI 10.1016-S0022-3476(82)80514-3; GREER FR, 1983, J PEDIATR GASTR NUTR, V2, pS277; GREER FR, 1981, J PEDIATR, V98, P696; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337-diabetes.51.5.1367; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073-pnas.121172198; GRIMSTON SK, 1992, BONE MINER, V19, P85, DOI 10.1016-0169-6009(92)90846-6; Grover SR, 2001, MED J AUSTRALIA, V175, P251; Guillemant J, 1995, BONE, V17, P513, DOI 10.1016-8756-3282(95)00401-7; Guillemant J, 2001, OSTEOPOROSIS INT, V12, P875, DOI 10.1007-s001980170040; GUNDBERG CM, 1983, J CLIN ENDOCR METAB, V56, P1063; Gysemans C, 2001, TRANSPLANT P, V33, P2365, DOI 10.1016-S0041-1345(01)02022-X; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016-0960-0760(95)00104-8; HADDAD JG, 1981, J CLIN INVEST, V67, P1550, DOI 10.1172-JCI110186; HADDAD JG, 1973, NATURE, V244, P515, DOI 10.1038-244515a0; HADDOCK L, 1982, P R HEALTH SCI J, V1, P85; HAGG U, 1980, ACTA ODONTOL SCAND, V38, P179, DOI 10.3109-00016358009004718; HALIOUA L, 1989, AM J CLIN NUTR, V49, P534; Harkness Laura S, 2005, J Adolesc Health, V37, P75, DOI 10.1016-j.jadohealth.2004.07.015; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359-jbmr.1998.13.3.325; Heaney RP, 2003, AM J CLIN NUTR, V77, P204; Heaney RP, 1997, J CLIN ENDOCR METAB, V82, P4111, DOI 10.1210-jc.82.12.4111; HEANEY RP, 1971, J CLIN ENDOCR METAB, V33, P661; Heaney RP, 2003, J AM COLL NUTR, V22, P142; Heaney RP, 2003, AM J CLIN NUTR, V78, P912; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007-s001980070020; Heaney RP, 2000, J CLIN ENDOCR METAB, V85, P3009, DOI 10.1210-jc.85.9.3009; HECKMATT JZ, 1979, LANCET, V2, P546; HENRIKSEN C, 1995, EUR J CLIN NUTR, V49, P211; HENRY HL, 1992, J CELL BIOCHEM, V49, P4, DOI 10.1002-jcb.240490103; HENRY HL, 1984, ANNU REV NUTR, V4, P493; Hewison M, 2003, J IMMUNOL, V170, P5382; Hill T R, 2006, Ir Med J, V99, P48; Hill TR, 2008, BRIT J NUTR, V99, P1061, DOI 10.1017-S0007114507842826; HILLMAN LS, 1988, J PEDIATR, V112, P864, DOI 10.1016-S0022-3476(88)80206-3; Holick MF, 2005, J NUTR, V135, p2739S; Holick Michael F, 2004, Am J Clin Nutr, V80, p1678S; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2008, J CLIN ENDOCR METAB, V93, P677, DOI 10.1210-jc.2007-2308; Hollis BW, 2004, AM J CLIN NUTR, V80, p1752S; HOLLIS BW, 1981, J NUTR, V111, P1240; HOLLIS BW, 1986, J CLIN ENDOCR METAB, V62, P41; Hollis BW, 2006, CAN MED ASSOC J, V174, P1287, DOI 10.1503-cmaj.060149; HOLLIS BW, 1986, METHOD ENZYMOL, V123, P167; Hollis BW, 2006, AM J CLIN NUTR, V84, P273; HOLMBERG I, 1990, BIOPHARM DRUG DISPOS, V11, P807, DOI 10.1002-bdd.2510110908; Houghton LA, 2006, AM J CLIN NUTR, V84, P694; HUGHES MR, 1978, J BIOL CHEM, V253, P1065; Huisman AM, 2001, J RHEUMATOL, V28, P2535; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016-S0140-6736(01)06580-1; Ilich JZ, 1997, CALCIFIED TISSUE INT, V61, P104, DOI 10.1007-s002239900304; Istfan NW, 2007, J STEROID BIOCHEM, V103, P726, DOI 10.1016-j.jsbmb.2006.12.011; JACOBSEN ST, 1986, J PEDIATR ORTHOPED, V6, P713; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016-S0140-6736(06)67922-1; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136-bmj.325.7359.305; Jian YZ, 2005, BIOCHEM BIOPH RES CO, V335, P739, DOI 10.1016-j.bbrc.2005.07.141; Jimenez-Lara AM, 2000, HORM RES, V54, P301, DOI 10.1159-000053276; JOHANSEN JS, 1988, J CLIN ENDOCR METAB, V67, P273; Jones G, 1998, J CLIN ENDOCR METAB, V83, P4274, DOI 10.1210-jc.83.12.4274; Jones G, 1999, EUR J CLIN NUTR, V53, P824, DOI 10.1038-sj.ejcn.1600858; Jones G, 2005, OSTEOPOROSIS INT, V16, P636, DOI 10.1007-s00198-004-1733-z; JONES G, 1980, J CLIN ENDOCR METAB, V50, P773; Jones IE, 2002, OSTEOPOROSIS INT, V13, P990, DOI 10.1007-s001980200137; Jones IE, 2000, NEW ZEAL MED J, V113, P443; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210-er.16.1.3; Judkins Annie, 2006, N Z Med J, V119, pU2144; Kalkwarf HJ, 2007, INT C SER, V1297, P39, DOI 10.1016-j.ics.2006.08.008; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016-j.autrev.2005.05.009; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332; Kaur M, 2003, ANN CLIN BIOCHEM, V40, P508, DOI 10.1258-000456303322326416; Kawai N, 1999, J CLIN ENDOCR METAB, V84, P82, DOI 10.1210-jc.84.1.82; KAWAKAMI M, 1981, J CLIN ENDOCR METAB, V53, P1110; KENT GN, 1990, J BONE MINER RES, V5, P361; Kim JH, 2000, INT J FOOD SCI NUTR, V51, P439, DOI 10.1080-09637480050208053; Kinyamu HK, 1998, AM J CLIN NUTR, V67, P342; KOEFFLER HP, 1985, BIOCHEM BIOPH RES CO, V127, P596; KOO WWK, 1984, PROG FOOD NUTR SCI, V8, P229; Kovacs CS, 2001, J CLIN ENDOCR METAB, V86, P2344, DOI 10.1210-jc.86.6.2344; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210-er.18.6.832; Kreiter SR, 2000, J PEDIATR, V137, P153, DOI 10.1067-mpd.2000.109009; KREUTZ M, 1993, BLOOD, V82, P1300; Kricker A, 2006, PROG BIOPHYS MOL BIO, V92, P132, DOI 10.1016-j.pbiomolbio.2006.02.015; Krill D, 2001, J CELL BIOCHEM, V82, P566, DOI 10.1002-jcb.1185; KUOPPALA T, 1986, HUM NUTR-CLIN NUTR, V40C, P287; LAMBERG-ALLARDT C, 1984, HUM NUTR-APPL NUTR, V38A, P377; LANDIN LA, 1983, ACTA ORHTOP SCAND S, V202, pS1; Lapatsanis D, 2005, CALCIFIED TISSUE INT, V77, P348, DOI 10.1007-s00223-004-0096-y; Lapillonne A, 2000, ACTA PAEDIATR, V89, P772, DOI 10.1080-080352500750043620; LAWSON DEM, 1986, CLIN CHIM ACTA, V157, P175, DOI 10.1016-0009-8981(86)90223-8; LAWSON DEM, 1986, BIOCHEM J, V233, P535; LeBoff MS, 1999, JAMA-J AM MED ASSOC, V281, P1505, DOI 10.1001-jama.281.16.1505; LEBRUN JB, 1993, CAN J PUBLIC HEALTH, V84, P394; Lehtonen-Veromaa M, 2000, J CLIN ENDOCR METAB, V85, P3726, DOI 10.1210-jc.85.10.3726; Lehtonen-Veromaa M, 1999, EUR J CLIN NUTR, V53, P746, DOI 10.1038-sj.ejcn.1600844; Lehtonen-Veromaa M, 2002, EUR J CLIN NUTR, V56, P431, DOI 10.1038-sj-ejcn-1601330; Lehtonen-Veromaa MKM, 2002, AM J CLIN NUTR, V76, P1446; Lerch C, 2007, COCHRANE DB SYST REV, DOI 10.1002-14651858.CD006164.pub2; Levis S, 2005, J CLIN ENDOCR METAB, V90, P1557, DOI 10.1210-jc.2004-0746; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006-clim.2000.4998; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210-jc.86.3.1212; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016-j.pbiomolbio.2006.02.016; LIU LT, 1994, J AM SOC NEPHROL, V5, P1251; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126-science.1123933; Looker AC, 2002, BONE, V30, P771, DOI 10.1016-S8756-3282(02)00692-0; LOPEZ SN, 2002, AN ESP PEDIATR, V57, P227; Lotborn M, 1999, OSTEOPOROSIS INT, V9, P106, DOI 10.1007-s001980050122; LUND B, 1980, ACTA ENDOCRINOL-COP, V94, P426; Luong QT, 2005, J STEROID BIOCHEM, V97, P195, DOI 10.1016-j.jsbmb.2005.06.017; Lyytikainen A, 2005, PUBLIC HEALTH NUTR, V8, P284, DOI 10.1079-PHN2004703; MAALOUFJ, 2008, J CLIN ENDO IN PRESS; MACLENNAN WJ, 1980, POSTGRAD MED J, V56, P75; Madelenat P, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, P761; Maghbooli Zhila, 2007, BMC Pregnancy Childbirth, V7, P1, DOI 10.1186-1471-2393-7-1; Mahomed K, 2000, COCHRANE DB SYST REV, V2; MAKIN G, 1989, BIOCHEM J, V262, P173; MALLET E, 1986, OBSTET GYNECOL, V68, P300; Mannion CA, 2006, CAN MED ASSOC J, V174, P1273, DOI 10.1503-cmaj.1041388; MANOLAGAS SC, 1985, MOL CELL ENDOCRINOL, V43, P113, DOI 10.1016-0303-7207(85)90074-7; MANOLAGAS SC, 1986, J CLIN ENDOCR METAB, V63, P394; MAOR G, 1989, ENDOCRINOLOGY, V125, P1239; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477; MARYA RK, 1981, ANN NUTR METAB, V25, P59, DOI 10.1159-000176479; MARYA RK, 1981, GYNECOL OBSTET INVES, V12, P155; MARYA RK, 1988, INDIAN J MED RES, V88, P488; Mathieu C, 2004, J STEROID BIOCHEM, V89-90, P449, DOI 10.1016-j.jsbmb.2004.03.014; MATHIEU C, 1992, DIABETES, V41, P1491, DOI 10.2337-diabetes.41.11.1491; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007-s00125-005-1802-7; Mathieu C, 2005, TRENDS ENDOCRIN MET, V16, P261, DOI 10.1016-j.tem.2005.06.004; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007-BF00403372; Matilainen M, 2005, NUCLEIC ACIDS RES, V33, P5521, DOI 10.1093-nar-gki872; MATKOVIC V, 1992, AM J CLIN NUTR, V55, P992; MATKOVIC V, 1994, J CLIN INVEST, V93, P799, DOI 10.1172-JCI117034; MATKOVIC V, 1991, AM J CLIN NUTR, V54, pS245; Matkovic V, 1996, J AM COLL NUTR, V15, P556; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136-bmj.323.7308.310; Matusiak D, 2005, CANCER EPIDEM BIOMAR, V14, P2370, DOI 10.1158-1055-9965.EPI-05-0257; MAURAS N, 1999, ACTA PAEDIATR, V88, pS81; Mauras N, 1996, HORM RES, V45, P74; MAWER EB, 1972, CLIN SCI, V43, P413; MAXWELL JD, 1981, BRIT J OBSTET GYNAEC, V88, P987, DOI 10.1111-j.1471-0528.1981.tb01686.x; McGrath JJ, 2005, CAN MED ASSOC J, V173, P733, DOI 10.1503-cmaj.1050100; MCKENNA MJ, 1992, AM J MED, V93, P69, DOI 10.1016-0002-9343(92)90682-2; Mee AP, 1996, J MOL ENDOCRINOL, V16, P183; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172-JCI114097; Merlino LA, 2004, ARTHRITIS RHEUM, V50, P72, DOI 10.1002-art.11434; Miller WL, 2000, TRENDS ENDOCRIN MET, V11, P315, DOI 10.1016-S1043-2760(00)00287-3; Molgaard C, 2003, P NUTR SOC, V62, P823, DOI 10.1079-PNS2003298; Mora S, 1999, J BONE MINER RES, V14, P1664, DOI 10.1359-jbmr.1999.14.10.1664; Mora S, 1998, CALCIFIED TISSUE INT, V63, P369, DOI 10.1007-s002239900542; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210-jc.2005-1479; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038-367284a0; Mosekilde L, 2005, CLIN ENDOCRINOL, V62, P265, DOI 10.1111-j.1365-2265.2005.02226.x; Mowe M, 1999, J AM GERIATR SOC, V47, P220; Mukamel MN, 2001, ISRAEL MED ASSOC J, V3, P419; MULLER K, 1995, CLIN RHEUMATOL, V14, P397, DOI 10.1007-BF02207671; Müller K, 1996, J Investig Dermatol Symp Proc, V1, P68; Munger KL, 2004, NEUROLOGY, V62, P60; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001-jama.296.23.2832; Murray LJ, 2000, OBSTET GYNECOL, V96, P689, DOI 10.1016-S0029
